Barbara Harding joined ISGlobal as a postdoctoral fellow in 2020. Her background is in Exercise Science (BS) and Epidemiology (PhD). She completed her doctoral studies in epidemiology at the University of Washington in Seattle, WA where she studied commonly used medications and survival from ovarian cancer.
Prior to coming to ISGlobal, she worked as a postdoctoral fellow at the Cardiovascular Health Research Institute in Seattle, WA, where she studied cardiovascular health and ageing, working on projects related to atrial fibrillation, cardiovascular side effects of medication use, marijuana use and cardiovascular health, and risk factors for hypertension.
Currently, she is working on projects related to circadian disruption and cardiovascular health and ageing.
Lines of research
- Cardiovascular health
- Circadian disruption
- Harding BN, Delaney JA, Urban RR, Weiss NS. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer. Gynecol Oncol. 2019 Aug;154(2):426-431.
- Harding BN, Weiss NS. Point: Immortal Time Bias-What Are the Determinants of Its Magnitude? Am J Epidemiol. 2019 Jun 1;188(6):1013-1015.
- Harding BN, Floyd JS, Scherrer JF, et al. Methods to identify dementia in the electronic health record: Comparing cognitive test scores with dementia algorithms. Healthc (Amst). 2020 Jun;8(2):100430.
- Harding BN, Wiggins KL, Jensen PN, McKnight B, Psaty BM, Heckbert SR, Floyd JS. Opioid, gabapentinoid, and nonsteroidal anti-inflammatory medication use and the risks of atrial fibrillation and supraventricular ectopy in the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1175-1182.
- Harding BN, Avoundjian T, Heckbert SR, et al. HIV viremia and risk of stroke among people living with HIV who are using antiretroviral therapy. Epidemiology. (In press)